This site uses cookies.

News Category 2

The Infected Blood Inquiry: Recent Updates in an Important Month - Nancy Kelehar, Temple Garden Chambers

14/05/24. The Infected Blood Inquiry was formed in 2017 and the final report of the Inquiry will be published later this month. On 20 May, the report will be published online and on the same date, the Chair of the Inquiry, Sir Brian Langstaff, will speak about his conclusions and recommendations at Central Hall, Westminster. The report should expose the extent of the failings of the NHS and other institutions that resulted in widespread infection and is likely to include important recommendations in relation to the extent of the compensation scheme.

The Government has recently indicated that it proposes to publish the details of its long-awaited compensation scheme, which could include a hierarchy of payments according to a defined tariff, very soon after the publication of the Inquiry’s final report. The Times has reported that the compensation package is expected to be northwards of £10 billion in total. However, victim groups are wary that the Government’s compensation announcement could be timed to dwarf reports on the full extent of the scandal as set out by the Inquiry, should an announcement be made on the same day as its final report.

Around 30,000 people in the UK are known to have been infected with viruses during the 1970s through to the early 1990s due to contaminated blood products. However, according to the BBC, alleged inadequate tracing of victims may mean that nearly 2,000 people have undiagnosed hepatitis C infections after transfusions with contaminated blood.

In another recent announcement, whilst bereaved children who lost parents as a result of their infected blood were not entitled to interim payments, this group are reportedly due to be included in the final compensation scheme.

Victims and campaigners have warned against any further delays to compensation as over 700 people impacted by infected blood products have died since the Inquiry began. Overall, there have been approximately 3,000 deaths due to treatments with contaminated blood.

The Inquiry Report will be published on its website on 20 May 2024.

Image ©iStockphoto.com/Jovanmandic

Upcoming Statutory Review of the Whiplash Tariff: but will reform follow? - Nancy Kelehar, Temple Garden Chambers

25/04/24. As readers will know, the whiplash tariff was introduced on 31 May 2021 under the Civil Liability Act 2018 (‘the Act’). Section 4(2) of the Act requires the Lord Chancellor to review the regulations within 3 years of their coming into force, i.e. by 31 May 2024. This upcoming review may result in increased figures under the tariff.

On 2 April 2024, the Ministry of Justice (MoJ) closed its Call for Evidence which it says forms a key part of the review of the whiplash tariff. The review is intended to assess the tariff and its component parts, and wider economic, sectorial and other factors since its introduction.

Of note to practitioners and claimants alike, the MoJ made reference in its Call for Evidence to “unexpected inflationary pressures” and noted that, despite the original figures being “uprated and future-proofed” using forecast CPI inflation between March 2021 and March 2024, the real value of the figures has fallen since their implementation (para 35).

On this basis, it seems likely that there will be at least some degree of uprating of the figures at some point in the near future, however it remains uncertain if and to what extent the figures will be uprated and when any new figures would come into effect. 

Additionally, CILEX (The Chartered Institute of Legal Executives) has responded to the Call for Evidence, stating that the compensation for PSLA in whiplash cases is “derisory and unfair” and fails to fully compensate claimants. CILEX argues that the current system which splits cases into ‘whiplash only’ and ‘whiplash plus minor psychological injuries’ is not a suitable approach, failing to reflect the complexity of psychological injury.

However, the extent to which reform will be forthcoming is uncertain, especially in light of the MoJ’s recent rejection for suggested changes to the Official Injury Claim (OIC) portal put forward by both claimant and defendant representatives.

Image ©iStockphoto.com/angelhell

Large and Small Apples, not Apples and Pears: Hassam v Rabot [2024] UKSC 1 - Amy Lanham Coles, Temple Garden Chambers

23/04/24. The long awaited Supreme Court decision in Hassam v Rabot is here. The Court of Appeal’s approach to “mixed” injuries (comprising both non-whiplash and whiplash injuries) has been endorsed.

BACKGROUND

This case confirms the approach to take in personal injury cases which are subject to the relatively new statutory regime laid down in the Whiplash Injury Regulations 2021. This regime limits the amount of compensation one can recover for whiplash injuries by reference to tariffs. A question arose as to how to value injuries where the Claimant sustains both whiplash and non-whiplash injuries.

The Defendant argued that the Claimants should be confined to the tariff sums unless the Claimant could prove that their non-whiplash injury had caused distinctive, i.e. “non-concurrent” PSLA (para 7).

The Claimant’s primary case was that the whiplash and non-whiplash injuries should be compensated without the need to make deductions in line with the well established principle in Sadler v Filipiak (para 8).

The Claimant’s secondary case, and the approach adopted by the majority in the Court of Appeal was to value the whiplash and non-whiplash injuries separately, add them together and then make the customary Sadler adjustment where necessary (para 9).

JUDGMENT

The Claimant’s secondary case was endorsed and the correct approach summarised at paragraph 52. The Supreme Court noted the mischief the statutory regime is designed to remedy (para 41) and the notion that any departure from the common law should be presumed to be as limited as possible (para 40). The tariff regime is designed to limit the amounts recoverable for whiplash injuries - not non whiplash injuries (para 37). It would be...

Image ©iStockphoto.com/gojak

Read more (PIBULJ subscribers only)...

Supreme Court Practice Note: 7 March 2024 - Amy Lanham Coles, Temple Garden Chambers

19/03/24. Be aware that the President of the Supreme Court issued a practice note on 7 March 2024 designed to encourage junior counsel to take a more prominent role in advocacy in the highest court.

Note in particular: “From 9 April 2024, when parties provide counsel’s agreed speaking times, the Supreme Court will also expect to receive confirmation, in instances where junior counsel are instructed but will not speak, that consideration has been given to whether junior counsel should have a speaking part.”

This falls to be considered in the context of the earlier statement from the Lady Chief Justice in the same vein in November 2023.

Image ©iStockphoto.com/bpperry

Permission granted to withdraw admission made 3 years earlier - Nancy Kelehar, Temple Garden Chambers

15/03/24. West v Bedfordshire Hospitals NHS Foundation Trust [2024] 2 WLUK 516

Date of Judgment: 28/02/2024

In these proceedings relating to a wrongful birth claim, the second defendant is a private ultrasound services company. In 2015, it had provided its services to the claimant following which the claimant’s daughter was born with spina bifida. The claimant’s case is that the foetal abnormalities should have been visible on those scans and resulted in further assessments. The 7-day trial on liability is listed for June 2024.

In a recent ex tempore judgment, the second defendant (D2) was granted permission pursuant to the updated CPR r.14.5 to withdraw admissions made over 3 years earlier. D2 had made admissions in a letter of response dated August 2020 and repeated in its Defence, in respect of certain breaches of duty based on evidence obtained from the sonographer. The application to withdraw those admissions was made on the basis that the original file handler had made a mistake or had misunderstood matters; the mistake was realised in August 2023 in consultation with counsel; it had not taken an unfair advantage in making later investigation of the claim more difficult; and it acted in good faith and promptly when the mistake was identified.

Rule 14.5 changed in October 2023 and now reads as follows:

In deciding whether to give permission for an admission to be withdrawn, the court shall consider all the circumstances of the case, including—

  • the grounds for seeking to withdraw the admission;
  • whether there is new evidence that was not available when the admission was made;
  • the conduct of the parties;
  • any prejudice to any person if the admission is withdrawn or not permitted to be withdrawn;
  • what stage the proceedings have reached; in particular, whether a date or period has been fixed for the trial;
  • the prospects of success of the claim or of the part of it to which the admission relates; and
  • the interests of the administration of justice.

This requires the court to consider all of the circumstances and the mere passage of time is not determinative. Further, the factors listed above are not exhaustive. Whilst the mistake or misunderstanding was a regrettable situation, the court held that D2’s application should be taken at face value. Rather than a deliberate or tactical decision, there had been an error of oversight. It was important to consider the overriding objective and avoid having a knee-jerk reaction to the passage of time. There was no evidential prejudice to the claimant, but significant prejudice to D2 and concern regarding the sonographer’s professional reputation. As a fair trial was still possible and there were four months until trial, the court granted the application in the circumstances.

In addition, the first defendant (D1) had made an application to substitute a new expert witness for its existing expert because its existing expert had since retired, would be out of the country for most of the year, and would have to pay additional premiums to the Medical Defence Union if he was the trial expert. The court applied the principles in Avantage (Cheshire) Ltd v GB Building Solutions Ltd (In Administration) [2023] 4 WLUK 38, exercised its discretion in accordance with the overriding objective and granted D1’s application, subject to the condition that the existing expert’s reports still had to be disclosed to the claimant.

Image ©iStockphoto.com/zilli

All information on this site was believed to be correct by the relevant authors at the time of writing. All content is for information purposes only and is not intended as legal advice. No liability is accepted by either the publisher or the author(s) for any errors or omissions (whether negligent or not) that it may contain. 

The opinions expressed in the articles are the authors' own, not those of Law Brief Publishing Ltd, and are not necessarily commensurate with general legal or medico-legal expert consensus of opinion and/or literature. Any medical content is not exhaustive but at a level for the non-medical reader to understand. 

Professional advice should always be obtained before applying any information to particular circumstances.

Excerpts from judgments and statutes are Crown copyright. Any Crown Copyright material is reproduced with the permission of the Controller of OPSI and the Queen’s Printer for Scotland under the Open Government Licence.